Archive - February 2022
Angelini Pharma’s Ontozry available for patients in Scotland with drug-resistant epilepsy
Let it Flow: COVID-19 LFT passes UK government assessment
Takeda Receives U.S. FDA Approval for Prefilled Syringe Presentation of Takhzyro (lanadelumab-flyo) for Use as a Preventive Treatment for Hereditary Angioedema Attacks
New management: Promising drug for people living with obesity
Need for Speed: Kidney cancer patients waiting three times longer
No green light from NICE for innovative cancer treatments
Celltrion submits application for inhaled COVID-19 antibody treatment
FDA Approves Juvéderm Volbella XC For Undereye Hollows
